Nutrien Ltd (NTR)

NYSE


	Symbol		Exchange		Currency
	NTR		NYSE		USD	Real-time
	0NHS		London		USD	Real-time
	NTR		CBOE Canada		CAD	Real-time
	NTR		Toronto		CAD	Real-time
	N7T		TradeGate		EUR	Delayed

Currency in USD

Disclaimer

48.57

-1.04(-2.10%)

Closed01:29:59

After Hours

48.58+0.01(+0.02%)

04:08:34

Fair Value

Day's Range

47.83

49.16

52 wk Range

44.65

62.53

NTR Income Statement

Featured here, the Income Statement (earnings report) for Nutrien Ltd, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Advanced Income Statement

Period Ending:

2014

31/12

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

Total Revenues

19,316

20,053

26,861

37,012

28,082

Total Revenues Growth

+2.9%

+3.82%

+33.95%

+37.79%

-24.13%

Cost Of Revenues

13,814

14,814

17,452

21,588

19,608

Gross Profit

5,502

5,239

9,409

15,424

8,474

Gross Profit Growth

+2.04%

-4.78%

+79.6%

+63.93%

-45.06%

Gross Profit Margin %

28.48%

26.13%

35.03%

41.67%

30.18%

Other Operating Expenses, Total

3,461

3,717

4,563

5,584

4,921

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+7.45%	+7.4%	+22.76%	+22.38%	-11.87%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	3,028	3,324	3,826	4,050	4,014
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	433	393	737	1,534	907

Operating Income

2,041

1,522

4,846

9,840

3,553

Operating Income Growth

-5.99%

-25.43%

+218.4%

+103.05%

-63.89%

EBIT Margin %

10.57%

7.59%

18.04%

26.59%

12.65%

Net Interest Expenses

-485

-474

-455

-459

-691

Net Interest Expenses Growth

-2.75%

+2.27%

+4.01%

-0.88%

-50.54%

Interest Expense, Total

-490

-475

-463

-484

-726

Interest And Investment Income

5

1

8

25

35

Other Non Operating Expenses, Total

-30

22

40

120

-87

EBT, Excl. Unusual Items

1,526

1,070

4,431

9,501

2,775

Gain (Loss) On Sale Of Assets

-

-6

-

-

-

Other Unusual Items, Total

-120

-872

-220

772

-774

EBT, Incl. Unusual Items

1,308

382

4,168

10,246

1,952

EBT, Incl. Unusual Items Growth

+1,154.84%

-70.8%

+991.1%

+145.83%

-80.95%

EBT, Incl. Unusual Items Margin

6.77%

1.9%

15.52%

27.68%

6.95%

Income Tax Expense

316

-77

989

2,559

670

Net Income to Company

992

459

3,179

7,687

1,282

Minority Interest

-

-

-26

-27

-24

Net Income

992

459

3,153

7,660

1,258

Net Income Growth

-72.24%

-53.73%

+586.93%

+142.94%

-83.58%

Net Income Margin %

5.14%

2.29%

11.74%

20.7%

4.48%

Preferred Dividend and Other Adjustments

-

-

-

-

-

Net Income to Common Excl. Extra Items

992

459

3,153

7,660

1,258

Basic EPS - Continuing Operations

1.7

0.81

5.53

14.23

2.53

Basic EPS - Continuing Operations Growth

+3,534.35%

-52.71%

+586.92%

+157.01%

-82.18%

Diluted EPS - Continuing Operations

1.7

0.81

5.52

14.18

2.53

Diluted EPS - Continuing Operations Growth

+3,500%

-52.6%

+585.08%

+156.88%

-82.16%

Basic Weighted Average Shares Outstanding

582.27

569.66

569.66

538.48

496.38

Diluted Weighted Average Shares Outstanding

583.1

569.69

571.29

540.01

496.99

Dividend Per Share

1.76

1.8

1.84

1.92

2.12

Dividend Per Share Growth

+7.98%

+2.27%

+2.22%

+4.35%

+10.42%

EBITDA

3,606

3,232

6,490

11,513

5,334

EBITDA Growth

-4.17%

-10.37%

+100.8%

+77.4%

-53.67%

EBITDA Margin %

18.67%

16.12%

24.16%

31.11%

18.99%

EBIT